Molecular Glue Drug Discovery & Screening Platforms Market
完整報告名稱與涵蓋範圍
Molecular Glue Drug Discovery & Screening Platforms Market Size, Share & Trends Analysis Report, By Platform Type (Phenotypic and Proteomics-Based Screening Platforms, DNA-Encoded Library and Chemoproteomic Platforms, AI and Computational Glue Design Platforms, Ligase and Target Mapping Technologies), By Offering (Platform Licensing and Partnered Discovery, Fee-for-Service Screening, Software and Data Products), By Application (Oncology, Immunology and Inflammation, Neurology and Other Areas), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The molecular glue drug discovery and screening platforms market covers the technologies, services and software used to discover and optimise molecular glues and other induced-proximity compounds, including phenotypic and global proteomics screening, DNA-encoded and chemoproteomic libraries, AI-driven design tools and ligase mapping technologies. Revenue is captured through platform licensing and partnered discovery agreements, fee-for-service screening and data products; the therapeutic products themselves are covered in a separate study.
Because glue discovery was long dependent on serendipity, platforms that can systematically identify ligase-target pairs and design compounds have become highly sought-after assets, evidenced by multi-target alliances with upfront payments and milestone structures reaching into the billions of dollars. Advances in quantitative proteomics throughput, covalent chemoproteomics, cryo-EM structural characterisation of ternary complexes and machine-learning models of surface complementarity are increasing hit rates and shortening cycle times. Contract research organisations and computational chemistry vendors are adding glue-specific workflows to serve pharmaceutical companies that prefer to build programs without full platform ownership.
Platform originators cluster in the United States and Europe, with Chinese CROs expanding screening services and Japanese and European pharmaceutical groups among the most active partners. Competition ranges from biotechnology companies monetising proprietary platforms to CROs and software vendors offering discovery capacity.
The InsightAce study delivers revenue forecasts in US$ across all platform type, offering, application and end user and regional segments for 2026-2035, alongside segment-level trend analysis, competitive landscape assessment and detailed company profiling.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Molecular Glue Drug Discovery & Screening Platforms Market Snapshot
Chapter 4. Global Molecular Glue Drug Discovery & Screening Platforms Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Platform Type Estimates & Trend Analysis
5.1. Platform Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Platform Type:
5.2.1. Phenotypic and Proteomics-Based Screening Platforms
5.2.2. DNA-Encoded Library and Chemoproteomic Platforms
5.2.3. AI and Computational Glue Design Platforms
5.2.4. Ligase and Target Mapping Technologies
Chapter 6. Market Segmentation 2: By Offering Estimates & Trend Analysis
6.1. Offering & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Offering:
6.2.1. Platform Licensing and Partnered Discovery
6.2.2. Fee-for-Service Screening
6.2.3. Software and Data Products
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
7.2.1. Oncology
7.2.2. Immunology and Inflammation
7.2.3. Neurology and Other Areas
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Pharmaceutical Companies
8.2.2. Biotechnology Companies
8.2.3. Academic and Research Institutes
Chapter 9. Molecular Glue Drug Discovery & Screening Platforms Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Monte Rosa Therapeutics, Inc.
11.2. Neomorph, Inc.
11.3. Proxygen GmbH
11.4. Magnet Biomedicine, Inc.
11.5. Triana Biomedicines, Inc.
11.6. Orionis Biosciences, Inc.
11.7. Bayer AG (Vividion Therapeutics)
11.8. Nurix Therapeutics, Inc.
11.9. Ambagon Therapeutics, Inc.
11.10. Seismic Therapeutic, Inc.
11.11. Evotec SE
11.12. Schrödinger, Inc.
11.13. HitGen Inc.
11.14. Insitro, Inc.
11.15. WuXi AppTec Co., Ltd.
圖表清單 List of Tables & Figures
Table 1. Global Molecular Glue Drug Discovery & Screening Platforms Market Revenue Forecast by Platform Type, 2026-2035 (US$ Mn)
Figure 1. Global Molecular Glue Drug Discovery & Screening Platforms Market Segmentation and Scope Overview
Table 2. Global Molecular Glue Drug Discovery & Screening Platforms Market Revenue Forecast by Offering, 2026-2035 (US$ Mn)
Figure 2. Global Molecular Glue Drug Discovery & Screening Platforms Market Share by Platform Type, 2026 & 2035
Table 3. Global Molecular Glue Drug Discovery & Screening Platforms Market Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 3. Molecular Glue Discovery Technology Stack from Screening to Ternary Complex Characterisation
Table 4. Global Molecular Glue Drug Discovery & Screening Platforms Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Platform Alliance Deal Values and Structures, 2022-2026
Table 5. Global Molecular Glue Drug Discovery & Screening Platforms Market Revenue Forecast by Region, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Molecular Glue Drug Discovery & Screening Platforms Growth Opportunity Analysis
Table 6. North America Molecular Glue Drug Discovery & Screening Platforms Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Competitive Positioning of Key Molecular Glue Drug Discovery & Screening Platforms Market Participants
Table 7. Europe Molecular Glue Drug Discovery & Screening Platforms Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Porter's Five Forces Analysis of the Global Molecular Glue Drug Discovery & Screening Platforms Market
Table 8. Asia Pacific Molecular Glue Drug Discovery & Screening Platforms Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Hit-Rate and Cycle-Time Improvements Enabled by Proteomics and AI Platforms
Table 9. Strategic Developments of Leading Molecular Glue Drug Discovery & Screening Platforms Market Participants, 2023-2026
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們